Biotech

All Articles

Basilea credit ratings $268M BARDA funding for antifungals, antibiotics

.Basilea Pharmaceutica's job developing brand-new antifungals has gotten a significant improvement f...

Capricor markets Europe rights to late-stage DMD treatment for $35M

.Having already gathered up the USA legal rights to Capricor Therapies' late-stage Duchenne muscle d...

FDA fragments adcomm for Applied's rare health condition medication

.After dismissing the choice date for Applied Therapeutics' metabolic condition medication govoresta...

Novo inks $600M NanoVation bargain to study hereditary medicines ex-liver

.Novo Nordisk is actually proceeding its own press in to hereditary medicines, accepting to compensa...

Innovent links cytokine to colorectal cancer reactions

.Innovent Biologics has actually produced the situation that its checkpoint inhibitor-cytokine combi...

Merck, Daiichi ADC reaches objective in stage 3 lung cancer cells study

.A stage 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) h...

Rakovina strengthens artificial intelligence focus with collab to choose cancer cells aim ats

.5 months after Rakovina Rehabs rotated towards artificial intelligence, the cancer-focused biotech ...

Ascendis' dwarfism medicine hits in phase 3, endangers BioMarin

.Ascendis Pharma has actually emerged as a potential danger to BioMarin's Voxzogo, reporting period ...

Despite ph. 3 miss, Alkeus views pathway ahead for eye health condition asset

.Though Alkeus Pharmaceuticals' dental eye disease property stopped working to dramatically reduce g...

Kairos goes public along with $6M IPO to finance trials of cancer cells drug

.With a trio of biotechs striking the Nasdaq on Friday, it was actually very easy to overlook a smal...